SGLT2 Inhibitor for Severe Tricuspid Regurgitation

Clinical trial NCT05686616 · UNKNOWN

Trial details

NCT number: NCT05686616
Sponsor: Samsung Medical Center
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Tricuspid Regurgitation

Start date: 2022-04-13
Primary completion: 2024-04-13
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.